Recruiting
Phase 2

PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Code:

NCT06245889

Conditions

Triple Negative Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Paclitaxel

Carboplatin

Pembrolizumab

Doxorubicin

Cyclophosphamide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information